• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24655 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     HAYES, Inc. Total wrist arthroplasty
2016     Agency for Healthcare Research and Quality (AHRQ) Total Worker Health®
2020     NIHR Health Technology Assessment programme Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT
2005     HAYES, Inc. Total sialic acid and lipid-associated sialic acid as tumor markers
2014     National Institute for Health and Care Excellence (NICE) Total prosthetic replacement of the temporomandibular joint. NICE interventional procedures guidance 500
2013     Institute of Health Economics (IHE) Total prosthetic replacement of the temporomandibular joint: a rapid evidence assessment and economic analysis
2015     HAYES, Inc. Total pancreatectomy with islet autotransplantation for chronic pancreatitis
2010     HAYES, Inc. Total Pancreatectomy with Autologous Islet Cell Transplantation (TP/AIT) for chronic pancreatitis
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Total Mesorectal Excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer - primary research
2007     Haute Autorite de sante (HAS) Total lumbar disc replacement
2005     Medical Advisory Secretariat (MAS) Total knee replacement: an evidence-based analysis
2003     Agency for Healthcare Research and Quality (AHRQ) Total knee replacement
2006     HAYES, Inc. Total hip resurfacing arthroplasty
2006     HAYES, Inc. Total hip resurfacing arthroplasty
2004     HAYES, Inc. Total hip replacement with hard-on-hard prostheses
2014     HAYES, Inc. Total hip replacement with hard on hard prostheses
2015     NIHR Health Technology Assessment programme Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation
2014     National Institute for Health and Care Excellence (NICE) Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip. NICE technology appraisal guidance 304
1996     University of York Total hip replacement
2013     Health Quality Ontario (HQO) Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures: a rapid review
2000     Medical Services Advisory Committee (MSAC) Total ear reconstruction
2017     National Institute for Health and Care Excellence (NICE) Total distal radioulnar joint replacement for symptomatic joint instability or arthritis. NICE interventional procedures guidance 595
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Total contact casts for diabetic foot ulcers: cost-effectiveness
2005     HAYES, Inc. Total artificial heart, temporary or permanent biventricular support device
2002     HAYES, Inc. Total artificial heart, temporary biventricular support device
2023     NIHR Health Technology Assessment programme Total ankle replacement versus ankle arthrodesis for patients aged 50–85 years with end-stage ankle osteoarthritis: the TARVA RCT
2010     HAYES, Inc. Total ankle replacement
2007     HAYES, Inc. Total ankle replacement
2011     HAYES, Inc. Total ankle replacement
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Total ankle arthroplasty
2024     National Institute for Health and Care Excellence (NICE) Toripalimab with chemotherapy for untreated advanced oesophageal squamous cell cancer (terminated appraisal). NICE technology appraisal guidance 1024
2016     National Institute for Health and Care Excellence (NICE) Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer. NICE technology appraisal guidance 389
2015     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
2006     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2009     National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of relapsed small-cell lung cancer. NICE technology appraisal guidance 184
2009     National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of recurrent and stage IVB cervical cancer. NICE technology appraisal guidance 183
2010     NIHR Health Technology Assessment programme Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix
2006     NIHR Horizon Scanning Centre (NIHR HSC) Topotecan (hycamtin) for carcinoma of the cervix: horizon scanning technology ultra-orphan note
2011     HAYES, Inc. Topoisomerase II alpha (TOP2A) testing to predict response to treatment of breast cancer
2008     HAYES, Inc. Topiramate for treatment of alcohol addiction
2003     WorkSafeBC Topiramate (Topamax) use in treating neuropathic pain
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Topical ozone therapy for the treatment of diabetic leg ulcers
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical oxygen treatment for wound healing: a review of clinical and cost-effectiveness
2017     HAYES, Inc. Topical oxygen therapy for chronic wound healing
2002     HAYES, Inc. Topical oxygen therapy for chronic wound healing
2001     ECRI Topical oxygen therapy for chronic wound healing
2008     NIHR Health Technology Assessment programme Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study
2010     Quality Improvement Scotland (NHS QIS ) Topical negative pressure therapy for wounds
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Topical diclofenac sodium
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2012     HAYES, Inc. Topical antiseptic products for preoperative skin preparation
2016     HAYES, Inc. Topera 3D mapping system (RhythmView Workstation and FIRMap) to guide ablation procedures for atrial fibrillation
2010     HAYES, Inc. Topaz MicroDebrider (ArthroCare Corp.) for treatment of tendons
2011     HAYES, Inc. Topaz microdebrider (ArthroCare Corp.) for treatment of tendon disorders of the upper extremities
2011     HAYES, Inc. Topaz MicroDebrider (ArthroCare Corp.) for treatment of tendon disorders of the upper extremities
2011     HAYES, Inc. Topaz microdebrider (ArthroCare Corp.) for treatment of tendon disorders of the lower extremities
2025     Penn Medicine Center for Evidence-based Practice (CEP) Tools for predicting imminent death
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tools assessing patient-reported outcome measures in cancer patients: accuracy and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tools and devices for the management of dementia in older adults: review of evidence-based guidelines
2007     Agency for Healthcare Research and Quality (AHRQ) Tool for evaluating core elements of hospital disaster drills
1999     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Tonsillectomy: scientific evidence, clinical practice and uncertainties
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Tonsillectomy, adenoidectomy and adenotonsillectomy for obstructive sleep apnoea: review of clinical evidence and guidelines
2006     National Institute for Health and Care Excellence (NICE) Tonsillectomy using ultrasonic scalpel. NICE interventional procedures guidance 178
2006     National Institute for Health and Care Excellence (NICE) Tonsillectomy using laser. NICE interventional procedures guidance 186
2015     NIHR Health Technology Assessment programme Tonsillectomy or adenotonsillectomy versus non-surgical management for sleep-disordered breathing in children
2008     Quality Improvement Scotland (NHS QIS ) Tonsillectomy for recurrent bacterial tonsillitis
2008     Quality Improvement Scotland (NHS QIS ) Tonsillectomy for recurrent bacterial tonsillitis
2017     Agency for Healthcare Research and Quality (AHRQ) Tonsillectomy for obstructive sleep-disordered breathing or recurrent throat infection in children
2023     NIHR Health Technology Assessment programme Tonsillectomy compared with conservative management in patients over 16 years with recurrent sore throat: the NATTINA RCT and economic evaluation
2007     Haute Autorite de sante (HAS) Tonsillectomy by guillotine dissection
2013     NIHR Horizon Scanning Centre (NIHR HSC) Tongue drive interface system for people with severe disability
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
2005     Adelaide Health Technology Assessment (AHTA) TomoTherapy HI-ART System(R): radiotherapy planning and treatment for cancer patients
2009     Adelaide Health Technology Assessment (AHTA) TomoTherapy HI-ART System radiotherapy planning and treatment for cancer
2015     National Institute for Health and Care Excellence (NICE) Tolvaptan for treating autosomal dominant polycystic kidney disease. NICE technology appraisal guidance 358
2024     Agency for Care Effectiveness (ACE) Tolvaptan for treating autosomal dominant polycystic kidney disease
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for heart failure (NYHA): horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for autosomal dominant polycystic kidney disease
2006     NIHR Horizon Scanning Centre (NIHR HSC) Tolevamer for clostridium difficile associated diarrhea: horizon scanning review
2022     Agency for Care Effectiveness (ACE) Tofacitinib, ustekinumab and vedolizumab for treating inflammatory bowel disease
2022     Agency for Care Effectiveness (ACE) Tofacitinib, ustekinumab and vedolizumab for treating inflammatory bowel disease
2021     National Institute for Health and Care Excellence (NICE) Tofacitinib for treating juvenile idiopathic arthritis. NICE technology appraisal guidance 735
2018     National Institute for Health and Care Excellence (NICE) Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs. NICE technology appraisal guidance 543
2023     National Institute for Health and Care Excellence (NICE) Tofacitinib for treating active ankylosing spondylitis. NICE technology appraisal guidance 920
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for psoriatic arthritis – second or subsequent line
2018     National Institute for Health and Care Excellence (NICE) Tofacitinib for moderately to severely active ulcerative colitis. NICE technology appraisal guidance 547
2017     National Institute for Health and Care Excellence (NICE) Tofacitinib for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 480
2012     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for moderate to severe chronic plaque psoriasis – second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for moderate to severe active ulcerative colitis
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for chronic plaque psoriasis – second line
2000     Institute for Clinical Systems Improvement (ICSI) Tocolytic therapy for preterm labor
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Tocolysis in preterm labour - a systematic review of evidence-based guidelines, effectiveness and health economic evaluations
2018     National Institute for Health and Care Excellence (NICE) Tocilizumab for treating giant cell arteritis. NICE technology appraisal guidance 518
2011     National Institute for Health and Care Excellence (NICE) Tocilizumab for the treatment of systemic juvenile idiopathic arthritis. NICE technology appraisal guidance 238
2011     NIHR Health Technology Assessment programme Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
2012     National Institute for Health and Care Excellence (NICE) Tocilizumab for the treatment of rheumatoid arthritis. NICE technology appraisal guidance 247
2009     NIHR Health Technology Assessment programme Tocilizumab for the treatment of rheumatoid arthritis
2021     European Network for Health Technology Assessment (EUnetHTA) Tocilizumab for the treatment of COVID-19
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Tocilizumab for rheumatoid arthritis